The PE Ratio as of December 2024 (TTM) for Anixa Biosciences, Inc. (ANIX) is -6.62

According to Anixa Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.62. This represents a change of -25.95% compared to the average of -8.94 of the last 4 quarters.

Anixa Biosciences, Inc. (ANIX) Historical PE Ratio (quarterly & annually)

How has ANIX PE Ratio performed in the past?

The mean historical PE Ratio of Anixa Biosciences, Inc. over the last ten years is -9.68. The current -6.62 PE Ratio has changed 6.74% with respect to the historical average. Over the past ten years (40 quarters), ANIX's PE Ratio was at its highest in in the April 2017 quarter at 28.05. The PE Ratio was at its lowest in in the January 2023 quarter at -15.93.

Anixa Biosciences, Inc. (ANIX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Anixa Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anixa Biosciences, Inc. (ANIX) Average PE Ratio

How has ANIX PE Ratio performed in the past?

The current PE Ratio of Anixa Biosciences, Inc. (ANIX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Anixa Biosciences, Inc. (ANIX) PE Ratio vs. Peers

How is ANIX’s PE Ratio compared to its peers?

Anixa Biosciences, Inc.’s PE Ratio is less than Cue Biopharma, Inc. (-1.19), less than INmune Bio, Inc. (-2.23), less than IN8bio, Inc. (-0.36), less than PolyPid Ltd. (-0.87), less than TFF Pharmaceuticals, Inc. (-0.02), less than Immunome, Inc. (-2.16), less than Annovis Bio, Inc. (-0.00), less than Aerovate Therapeutics, Inc. (-0.87), less than Adagene Inc. (-2.59), less than Acrivon Therapeutics, Inc. Common Stock (-3.15), less than Rezolute, Inc. (-4.47), less than AN2 Therapeutics, Inc. (-0.69), less than Anebulo Pharmaceuticals, Inc. (-4.09), less than Mineralys Therapeutics, Inc. (-3.92), greater than Arcellx, Inc. (-102.24), less than PMV Pharmaceuticals, Inc. (-1.51), less than Molecular Partners AG (-2.46),

Build a custom stock screener for Anixa Biosciences, Inc. (ANIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anixa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anixa Biosciences, Inc. (ANIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anixa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.